Arcadia Biosciences, Inc.
RKDA
$2.95
-$0.2096-6.63%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -63.56% | -58.11% | -56.19% | -63.04% | -43.61% |
| Total Receivables | 506.52% | 791.12% | 312.54% | -17.66% | -58.56% |
| Inventory | 8.00% | -68.57% | -69.09% | -29.33% | -63.94% |
| Prepaid Expenses | 15.37% | -52.33% | -43.53% | -11.72% | 1.51% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -91.86% | -72.22% | 143.68% | -82.76% | 182.97% |
| Total Current Assets | -38.27% | -46.46% | -46.72% | -57.21% | -41.05% |
|
|
|||||
| Total Current Assets | -38.27% | -46.46% | -46.72% | -57.21% | -41.05% |
| Net Property, Plant & Equipment | -79.35% | -77.65% | -70.83% | -54.33% | -65.90% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | -2.50% | -2.50% | -2.50% | -2.50% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.90% | 128.81% | 193.49% | 261.30% | 300.84% |
| Total Assets | -31.40% | -35.05% | -35.19% | -47.23% | -31.87% |
|
|
|||||
| Total Accounts Payable | 44.95% | -34.97% | -43.95% | -37.81% | -46.41% |
| Total Accrued Expenses | -12.65% | -34.78% | 142.42% | 400.00% | -10.44% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -81.81% | -62.55% | -43.30% | -21.01% | -15.64% |
| Total Finance Division Other Current Liabilities | -43.44% | -16.93% | 75.53% | -4.59% | 16.67% |
| Total Other Current Liabilities | -43.44% | -16.93% | 75.53% | -4.59% | 16.67% |
| Total Current Liabilities | -28.61% | -40.08% | -34.05% | -29.75% | -14.71% |
|
|
|||||
| Total Current Liabilities | -28.61% | -40.08% | -34.05% | -29.75% | -14.71% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -97.93% | -97.24% | -84.61% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 45.26% | -27.95% | -30.39% | -69.94% | 16.07% |
| Total Liabilities | 4.17% | -36.89% | -36.01% | -59.45% | -12.72% |
|
|
|||||
| Common Stock & APIC | 0.18% | 0.19% | 0.20% | 0.23% | 2.04% |
| Retained Earnings | -2.59% | -2.17% | -2.55% | -2.63% | -5.42% |
| Treasury Stock & Other | -- | 34.48% | 285.71% | -- | -- |
| Total Common Equity | -51.54% | -33.79% | -34.50% | -36.87% | -38.95% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -51.54% | -33.79% | -34.50% | -36.87% | -38.95% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | 0.00% | 0.00% | -3.76% | -3.76% |
| Total Equity | -51.01% | -34.09% | -34.77% | -37.20% | -39.22% |
|
|
|||||